Related Experiment Video
Updated: Feb 8, 2026
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Vaccination with RSV M209-223 peptide promotes a protective immune response associated with reduced pulmonary
Tiago Fazolo1, Rodrigo Benedetti Gassen1, Deise Nascimento de Freitas2
1Laboratory of Cellular and Molecular Immunology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil; Laboratory of Clinical and Experimental Immunology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Abstract:
Respiratory syncytial virus (RSV) is the most common etiologic agent in severe infections of the lower respiratory tract in children with a high mortality rate. However, there are still no licensed vaccines for RSV. In this study, we investigated a putative vaccine based on M209-223 peptide. Mice vaccinated with M209-223 peptide expanded M209-223-specific effector CD4+ T cells upon infection. Vaccination resulted in increased numbers of regulatory T cells (Treg) and Th1 cells, and decreased numbers of Th2 cells. In addition, vaccination with M209-223 peptide, protected mice from infection and prevented lung inflammation, leading to increase in IL-10 and IFN-γ production by lung CD4+ T cells. Treg depletion with anti-CTLA4 antibodies abrogated protection induced by peptide vaccination. Our results support vaccination with M209-223 peptide as an important strategy to generate protection, both systemic and local, by memory RSV-specific CD4+ T cells in mice. Contrarily to inactivated RSV particles, M209-223 peptide vaccination is capable of not only promoting viral clearance, but also reducing inflammatory processes in lungs upon infection.
Insights
A novel Respiratory Syncytial Virus (RSV) peptide vaccine (M209-223) shows promise in mice. It generates protective T cells, reduces lung inflammation, and prevents severe infection, offering a new vaccine strategy.
Area of Science:
- Immunology
- Vaccinology
- Virology
Background:
- Respiratory Syncytial Virus (RSV) causes severe lower respiratory tract infections in children, with high mortality.
- Currently, no licensed vaccines are available for RSV prevention.
- Developing effective RSV vaccines remains a critical public health challenge.
Purpose of the Study:
- To investigate the efficacy of a novel vaccine strategy using the M209-223 peptide for Respiratory Syncytial Virus (RSV).
- To evaluate the immunological responses and protective effects of M209-223 peptide vaccination in a murine model.
Main Methods:
- Mice were vaccinated with the M209-223 peptide.
- Immunological responses, including CD4+ T cell populations (Treg, Th1, Th2), were analyzed post-infection.
- Lung inflammation, viral clearance, and cytokine production (IL-10, IFN-γ) were assessed.
- The role of regulatory T cells (Treg) was investigated using anti-CTLA4 antibodies.
Main Results:
- M209-223 peptide vaccination induced M209-223-specific effector CD4+ T cells.
- Vaccination increased regulatory T cells (Treg) and Th1 cells, while decreasing Th2 cells.
- Mice vaccinated with the peptide were protected from RSV infection and lung inflammation, with increased IL-10 and IFN-γ production.
- Depletion of Treg cells abrogated the protective effects of the peptide vaccination.
Conclusions:
- Vaccination with the M209-223 peptide is a viable strategy for generating systemic and local protection against RSV in mice.
- This peptide-based approach elicits protective memory RSV-specific CD4+ T cells.
- Unlike inactivated RSV, M209-223 peptide vaccination promotes viral clearance and reduces lung inflammation.
Related Concept Videos
01:51Vaccinations
01:38Inflammation
01:36Humoral Immune Responses
01:40Cell-mediated Immune Responses
01:23Cells of the Adaptive Immune Response
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...